Cancer drug combo trial halted early after enrolling only 2 patients
Disease control
Terminated
This study tested a new radioactive drug (225Ac-SSO110) combined with standard treatments for people with advanced small cell lung cancer or Merkel cell carcinoma. The goal was to find a safe dose and see if the drug shrank tumors. However, the trial was stopped early after enrol…
Phase: PHASE1, PHASE2 • Sponsor: Ariceum Therapeutics GmbH • Aim: Disease control
Last updated May 17, 2026 04:17 UTC